21.09.2012
Fora Care to Unveil New Mobile App, Featuring Advanced Mobile Connectivity of FORA Diamond Series Blood Glucose Monitoring System at EASD 2012 in Berlin at Booth #3C41
Company to Showcase Mobile App, iFORA, and New Mobile Integration of Bluetooth Enabled Diamond Series for Complete Telehealth Solution
St. Gallen, Switzerland (PRWEB UK) 20 September 2012

Fora Care Suisse AG located in St. Gallen, Switzerland, announced today it will be exhibiting at the European Association for the Study of Diabetes (EASD) meeting October 2-5, 2012 in the Messe Berlin Exhibition Halls in Berlin-Charlottenburg, Germany to showcase the latest in diabetes monitoring with its new mobile application (app), iFORA. The program integrates with Fora Care’s FORA Diamond series products and allows users to transmit their health monitoring data to their mobile device. Fora Care’s booth is #3C41. Fora Care’s new app, iFORA, gives diabetes patients the ability to transmit their individual glucose data from their glucose meter to their mobile devices through Bluetooth connectivity. The program can be used for both iOS (including iPhone®) and Android® systems.

To view the new app, visit iTune App Store or  Google Play.

“Fora Care Suisse AG is honored to present to the European market and our distributors and customers. We will be presenting the latest in blood glucose monitoring with our new iFORA mobile application that integrates with our devices and Telehealth System,” said Ty-Minh Tan, CEO of Fora Care Suisse AG. “We are committed to delivering high quality, accurate products to the market that our customers can depend on.”

FREEDOM FROM PAPER LOGBOOKS The iFORA app provides a simple-to-use program that eliminates the need for paper logbooks and can sort and organize glucose data quickly and easily, allowing users to gain a better understanding of their own health situation in real time. As an example, users who are managing their health using personal monitoring devices, blood glucose data can be easily integrated to help them stay within their target ranges for food intake and exercise and allow for easier medication adherence. A simple trend chart shows them how they are doing and whether they are on track, allowing them to make up-to-the-minute adjustments to maintain optimal control of their diabetes and overall health. Easily integrated via Fora Care’s TeleHealth System, iFORA allows patients easily transmit information from their mobile device to their medical professional, whenever and wherever, allowing better self management and providing a tool for doctors to respond in real time to patient need by analyzing the data provided by the patient. BLOOD GLUCOSE MONITORING Fora Care will also present its FORA Diamond line of glucose meters featuring new SSI Technology that provides five main improved performance features: fast blood absorption (completes within five seconds), testing from most any angle, easier strip handling, reduced strip wastage and more accuracy in test results. Fora Care’s Diamond products, Diamond Prima, Voice, Mini and iDiamond, deliver solutions for better self-management through the Fora Care TeleHealth System. The innovative technology enables users to update their blood glucoses level on mobile devices (iOS and Android platform enabled) instantly and transmit data to the TeleHealth system, allowing them to upload data whenever, wherever and share information with their family and physician if desired.

All ForaCare monitoring devices are validated as highly accurate in the industry and provide superior quality directly to consumers. FORA Blood Glucose Monitors are validated according to ISO 15197 requirements at an internationally renowned diabetes institute in Ulm, Germany. Fora Care provides FDA cleared and CE marked innovative health monitoring devices that provide simple connection to the FORA system. For more information, please visit http://www.ForaCare.ch

About ForaCare Suisse AG: http://www.foracare.ch

Contact:

Elena Birrer

Elena.birrer@foracare.com

+41-71-220-1001

SOURCE ForaCare Suisse AG

UBS